This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Read More
Oxycodone Market by Oxycodone Type (Long-acting oxycodone, Short-acting oxycodone), Application (Pain Management, De-addiction), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) & Region - Forecast to 2021-2031

Oxycodone Market by Oxycodone Type (Long-acting oxycodone, Short-acting oxycodone), Application (Pain Management, De-addiction), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) & Region - Forecast to 2021-2031

Oxycodone Market - Analysis, Outlook, Growth, Trends, Forecasts

Oxycodone Market Snapshot

As per recently updated report by Future Market Insights, oxycodone sales will rise consistently at 4.8% CAGR between 2021 and 2031. Driven by surging demand for effective pain management solutions, the oxycodone market valuation is forecast to surpass US$ 4.6 Bn in 2021.

Growth predictions remain positive for North America due to increasing healthcare expenditure in the U.S. and Canada. Spurred by this, the North America oxycodone worth is projected to reach US$ 1.85 Bn in 2021.

Key Points Covered in Oxycodone Market Study

  • Market estimates and forecast 2021 – 2031
  • Key drivers and restrains impacting market growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competitive Mapping and Benchmarking
  • Brand share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact On Oxycodone Market
  • Recommendation on Key Winning Strategies

2016 – 2020 Oxycodone Market Outlook In Comparison to 2021 – 2031 Forecast

The demand for pain management medication is rising consistent, which will create prospects for expansion of the oxycodone market. According to FMI, the market exhibited a CAGR of 5% between 2016 and 2020. 

The growth trend will continue in response to increasing healthcare spending registered globally. Considering this, the rising cases of chronic ailments such as rheumatoid arthritis will rev up growth opportunities for the market.

Oxycodone is known as a type of opioid consumed to monitor pain management, anaesthesia, and de-addiction. There are usually two types of oxycodone form based on their component, one being long-activity component and other short-activity component.

They are also known to provide relief after operation, surgeries, and other medical conditions, thus boosting the demand for oxycodone in the global market.

Rising number of chronic diseases such as fibromyalgia, arthritis, lower back pain, and others is accelerating the demand for pain relieving opioids.

The demand for oxycodone is expected to rise globally as it is prescribed as an analgesic for post-operative pain, HIV, and cancer medication. According to the Centre for Disease Control and Prevention, 239 million surgeries were conducted in 2013.

Around 65% of the patients witnessed moderate to severe post-operative pain therefore, bolstering the adoption of oxycodone market as an opioid pain management drug.

The global oxycodone market is expected to face certain restrains as there has been an increased opioid abuse and mortality. In 2017, opioid has led to 66% of drug overdose deaths in the U.S alone. However, in the coming years, the market will gain from government support and development of new drug that do not cause addiction.

How will Increasing Prevalence of Chronic Diseases Affect Oxycodone Market?

Rising number of chronic disorders has been shaping the growth of the oxycodone market. It is often prescribed for pain management post surgeries. One of the key driving factors is the rising prevalence of Parkinson’s syndrome.

According to BlueCross BlueShieldm prevalence of Parkinson’s disease is gradually rising in young adults. Also, as per Parkinson’s Foundation, in the U.S., nearly 1 million people are living with the condition. 

Parkinson’s patients with severe pain are sometimes prescribed long-acting oxycodone treatment. They showed relevant clinical improvements relative to placebo.

Rheumatic and cancer patients also benefit from oxycodone as it helps in improving pain management. Oxycodone is also primarily used as pain reliever after operations and surgeries thus, gaining momentum from these developments.

Considering this, the rising application of oxycodone in pain management will create scope for expansion of the market in the near future.

Restrains Give Way to New Development in the Global Oxycodone Market

Opioids aid majorly in relieving pain therefore, they are classified as addictive in nature. Although they provide cost-effective solutions to patients suffering from pain caused due to various ailments, they are addictive in nature and therefore can be abused.

Opioid consumption has major side effects such as euphoria, slowed breathing, nausea, constipation, drowsiness, and confusion. Research and development activities along with government reimbursement to develop oxycodone drugs to prevent addiction associated with opioids are likely to open new gateways for market growth during the forecast period.

Increased new drug applications and products in the pipeline in pharmaceutical companies will drive the market for oxycodone.

Country-wise Analysis

Will U.S. Remain a Key Oxycodone Market?

The U.S. is expected to lead the global market as this country has substantial purchasing power owing to its large economy. According to National Health Accounts by Centers for Medicare & Medicaid Services (CMS), healthcare spending in the country grew by 4.6% in 2019.

With expenditure on healthcare forecast to rise further, the demand for oxycodone will continue rising in the U.S. The market also will gain from rising cases of chronic ailments in the country.

This country also showcases the presence of key players such as Purdue Pharma, Pfizer Inc., Janssen Pharmaceuticals Inc., Endo Pharmaceuticals, and others. Therefore, the oxycodone market in the U.S. is likely show promising growth in the coming years.

How Will Oxycodone Market Growth Unfold in GCC Countries?

Gulf countries dominate the Middle East and Africa oxycodone market due to their substantial wealth and public healthcare expenditure.

According to 2018 GCC Healthcare Industry Report compiled by Alpen Capital, healthcare expenditure in the region is expected to reach over US$ 104 Bn by 2022.

With demand for advanced healthcare consistently rising, GCC countries will offer impressive growth opportunities for the oxycodone market.

What are the Factors Driving Oxycodone Demand in the U.K.?

According to the Office of National Statistics, U.K., in 2018, the healthcare expenditure in the U.K. accounted for 10% which was £214.4 billion. Government financed healthcare expenditure grew by 2.0%.

Increasing healthcare expenditure in the country is related to the rising cases of chronic ailments. Thanks to better access to information, not only are people better aware about various medical conditions, they are willing to spend on advanced healthcare.

This is expected to reflect positively on the U.K. market, presenting conducive environment for the growth of oxycodone sales.

What are the Factors Driving Oxycodone Market Growth in India?     

According to Indian Council of Medical Research (ICMR) and India’s National Centre for Disease Informatics and Research, the number of cancer cases in male alone is around 6,79,421 and will likely reach 7,63,575 by 2025.

The rise of cancer cases will fuel the demand for pain management solutions. This will bode well for the oxycodone market growth in India.

Besides this, expansion of the healthcare sector to support soaring healthcare needs of its citizens, will create opportunities for growth in India.

Category-wise Insights

Why is long-acting oxycodone gaining popularity?

Long acting oxycodone is expected to register higher sales compared to short acing oxycodone as it has reduced frequency of dosing and provide extended analgesia over longer intervals.

It is known to provide extended treatment for patients with persistent pain levels and for those on whom non-opioid treatment has failed to provide tolerable analgesia.

Its demand is expected to rise as it provides consistent and prolonged plasma dug levels with lesser peak and trough fluctuations. Additionally, long acting oxycodone provide improved dosing schedule and reduces clock-watching between doses.

Why hospital pharmacies will exhibit more demand?

Hospital pharmacies are expected to grow substantially during the forecast period owing to large scale development of specialty hospitals and increased purchasing powers. Increasing penetration of healthcare insurance and consolidation of healthcare giants are expected to drive the hospital pharmacies further.

Competitive Landscape

The global oxycodone market is highly fragmented as there are numerous notable players operating in the market. Key players are actively investing in research development activities to expand their product portfolio along with adopting strategies such as mergers, joint ventures, and acquisition to stay ahead in the competition.

For instance:

  • Teva Pharmaceutical Industries Ltd. got FDA approval for VANTRELATM ER extended-release tablets that were formulated with Teva’s proprietary abuse deterrence technology for managing daily severe pain. The product’s approval was supported by a clinical program to evaluate efficacy, safety, and abuse potential of VANTRELA ER.
  • Purdue Pharma signed an agreement with U.S. Department of Justice to deliver more than $10 billion in value opioid crisis to communities and claimants.
  • Mylan and Pfizer collaborated under combination of Mylan and Upjohn to form Viatris. The company is expected to flourish into a sustainable healthcare journey by expanding medicine access and meeting patient needs.

Leading oxycodone manufacturers as profiled by FMI include:

This list is indicative - full details about prominent oxycodone manufacturers is available upon request

Oxycodone Market – Report Scope



Forecast Period

2021 – 2031

Historical Data Available for

2016 – 2020

Market Analysis

US$ Mn for Value & Units for Volume

Key Regions Covered

North America, Latin America, Europe, Asia Pacific and  Middle East & Africa

Key Countries Covered

US, Canada, Brazil, Mexico, Argentina, Germany, UK, Spain, France, Italy, Russia, India, China, Japan, South Korea, the Philippines, Malaysia, Thailand, Australia, New Zealand, GCC, Turkey, Israel, Turkey, Iran and South Africa

Key Segments Covered

Product type, Application segment, Distribution channel and Region

Key Companies Profiled

  • Teva Pharmaceutical Industries Ltd.
  • Purdue Pharma L.P
  • Daiichi Sankyo
  • Acorda Therapeutics
  • Teikoku Pharma USA, Inc.
  • Mylan N.V
  • Endo Pharmaceuticals Inc.
  • Janssen Pharmaceuticals, Inc.

Report Coverage

Market Overview, Market Background, Market Forecast, Segmental Analysis, Regional Profiling and Competition Analysis

Customization & Pricing

Available upon Request

Enquiry before Buying

  • Is the market research conducted by Future Market Insights?

    Yes, the report has been compiled by expert analysts of Future Market Insights, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

  • What research methodology is followed by Future Market Insights?

    FMI follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

  • Who are the respondents for primary research?

    FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

  • What are the sources of secondary research?

    FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

  • Is a sample of this report available for evaluation?

    Yes, you can request a sample, and it will be sent to you through an email.

  • How can I buy this report?

    FMI provides a secure online payment system to buy reports seamlessly. You can buy the report securely and safely

Sign Up with MarketNgage

World's Most Profilic Intelligence Engine

Get Access To The World's Largest Market Research Database.

Sign Up Now

Key Segments Covered in Oxycodone Market Study

By Oxycodone Type:

  • Long-acting oxycodone
  • Short-acting oxycodone

By Application:

  • Pain Management
  • De-addiction

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Questions Answered in the Report

What is oxycodone market size?

Driven by increasing demand for pain management solutions, the oxycodone market size is forecast to reach US$ 4.6 Bn in 2021
Between 2016 and 2020, the oxycodone sales surged at a 5% CAGR. The market’s valuation stood at US$ 3.67 Bn in 2020.
There is increase focus on new drug development in the market. Companies are currently focusing on discovery of abuse-deterrent drugs. Besides this, launch of extended-release medications are expected to bode well for the oxycodone market.
Rising prevalence of chronic ailments and the resultant demand for effective pain management solutions will remain the chief growth driver. The market also will gain from rising spending on advanced healthcare.
Demand registered in North America will continue rising, backed increasing sales in the U.S. and Canada, the North America market will reach a valuation of US$ 1.85 Bn in 2021.
Purdue Pharma LP, Pfizer Inc., Janssen Pharmaceuticals, Inc., Teva Pharmaceuticals, Endo International Plc, West-Ward Pharmaceuticals (Hikma’s US subsidiary), Mallinckrodt Pharmaceuticals Plc, Mylan N.V, Impax Laboratories, Inc, and Indivior Plc. Are the top ten companies in the market.
Top players account for nearly 35% to 40% of the oxycodone market
Oxycodone sales will increase at 5% CAGR in Europe, backed by rising demand in the U.K., Germany, and other countries.
Leading countries driving demand in the oxycodone market are the U.S., France, the U.K., Japan, and Australia.
Japan and South Korea held 3.2% and 0.5% share, respectively in the overall oxycodone market in 2020.

Need specific information?

Our Clients


View All Reports from Healthcare

View Reports



Animal Model Market

Published : 2022-01-06


Orthokeratology Market

Published : 2022-01-05


Disposable Laparoscopic Instruments Market

Published : 2022-01-12


Enzyme Replacement Therapy Market

Published : 2022-01-11